期刊文献+

ABT-263对顺铂耐药食管癌细胞的抑制作用

Inhibitory effect of ABT-263 on cisplatin-resistant esophageal cancer cells
下载PDF
导出
摘要 目的研究ABT-263对顺铂耐药食管癌细胞EC109/CDDP的作用。方法采用MTT法检测ABT-263对耐药细胞EC109/CDDDP及其亲代细胞EC109的细胞毒作用;通过克隆存活实验检测ABT-263对食管癌细胞再生能力的影响;流式细胞术检测细胞凋亡的情况,并通过Western blot检测细胞PARP蛋白的变化。结果 MTT实验结果显示ABT-263对EC109及EC109/CDDP的细胞活力均有显著抑制作用;克隆存活实验结果显示ABT-263可以抑制食管癌细胞的再生能力(P <0.01);流式凋亡结果分析显示ABT-263诱导食管癌细胞发生细胞凋亡(P <0.01);Western blot结果显示ABT-263显著上调细胞PARP蛋白的剪切(P <0.05或P <0.01)。结论ABT-263抑制食管癌EC109/CDDP细胞及其亲代细胞EC109的细胞活力和增殖能力,诱导细胞发生凋亡。 Objective To investigate the effect of ABT-263 on cisplatin-resistant esophageal cancer cell line of EC109/CDDP.Methods The cytotoxicity of ABT-263 in the cisplatin-resistant cell line EC109/CDDP and its parental cell line EC109 was measured by MTT assay.Colony formation assay was used to determine the effect of ABT-263 on cell renewable capacity of esophageal cancer cells.Flow cytometry was adopted to detect cell apoptosis.Western blot was used to investigate the changes of protein expression of PARP.Results MTT assay results showed that ABT-263 significantly inhibited the cell viability of EC109 and EC109/CDDP.Colony formation assay indicated that ABT-263 inhibited the cell renewable capacity of esophageal cancer cells(P﹤0.01).Flow cytometry analysis revealed that ABT-263 induced apoptosis of esophageal cancer cells(P﹤0.01).Western blot results showed that ABT-263 significantly increased the protein expression of cleavage PARP(P<0.05 or P﹤0.01).Conclusion ABT-263 exhibits cytostatic and cytotoxic effects on cisplatin-resistant esophageal cancer cell line EC109/CDDP and its parental cell line EC109,while it induces apoptosis.
作者 林庆焕 丁茸 毕婷婷 林健 邓贵华 LIN Qinghuan;DING Rong;BI Tingting;LIN Jian;DENG Guihua(Pharmacy Department,Guangdong Women and Children Hospital,Guangdong Province,Guangzhou 510010,China;Pharmacy Department,Songgang People′s Hospital of Shenzhen City,Guangdong Province,Shenzhen 518105,China)
出处 《中国医药导报》 CAS 2019年第2期12-16,共5页 China Medical Herald
关键词 ABT-263 食管癌 顺铂耐药 凋亡 ABT-263 Esophageal cancer Cisplatin-resistant Apoptosis
  • 相关文献

参考文献4

二级参考文献165

  • 1李美宁,黄革,郭黎平,陆士新.食管癌相关基因2对EC9706细胞恶性增殖的抑制作用[J].中华医学杂志,2005,85(39):2785-2788. 被引量:9
  • 2Wang Z, Tang L, Sun G, et al. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China[J]. BMC Cancer, 2006, 6: 287.
  • 3Sepehr A, Taniere P, Martel-Planche G, et al. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran[J]. Oncogene, 2001, 20(50): 7368-74.
  • 4llson DH. Esophageal cancer chemotherapy: recent advances [J]. Gastrointest Cancer Res, 2008, 2(2): 85-92.
  • 5Holzer AK, Samimi G, Katano K, et al. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells[J]. Mol Pharmacol, 2004, 66(4):817-23.
  • 6Samimi G, Safaei R, Katano K, et al. Increased expression of the copper effiux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells[J]. Clin Cancer Res, 2004, 10(14): 4661-9.
  • 7Yu L, Wu WK, Li Z J, et al. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/ activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma [J]. J Pharmacol Exp Ther, 2008, 327(1): 258-67.
  • 8Wen J, Zheng B, Hu Y, et al. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line[J]. Oncol Rep, 2009, 22(1): 65-71.
  • 9Hall MD, Okabe M, Shen DW, et al. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy[J]. Annu Rev Pharmacol Toxicol, 2008, 48: 495-535.
  • 10Rebillard A, Lagadic-Gossmann D, manche-Boitrel MT. Cisplatin cytotoxicity: DNA and plasma membrane targets [J]. Curr Med Chem, 2008, 15(26): 2656-63.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部